重视肿瘤相关性缺血性卒中患者的识别与管理 Focusing on the Identification and Management of Patients with Cancer-Associated Ischemic Stroke

• Published in: Zhongguo cuzhong zazhi Vol. 20; no. 2; pp. 131 - 136
• Main Author: 徐炳东，林英泽，王舒泓，杨丹萍，徐安定，张玉生（XU Bingdong, LIN Yingze, WANG Shuhong, YANG Danping, XU Anding, ZHANG Yusheng）
• Format: Journal Article
• Language: Chinese
• Published: Editorial Department of Chinese Journal of Stroke 01.02.2025
• Subjects: cancer-associated ischemic stroke; diagnosis; multidisciplinary collaboration; treatment; 多学科协作; 治疗; 肿瘤相关性缺血性卒中; 诊断
• DOI: 10.3969/j.issn.1673-5765.2025.02.001
• ISSN: 1673-5765

肿瘤相关性缺血性卒中（cancer-associated ischemic stroke，CAIS）是一类临床表现复杂、复发风险高且预后不佳的疾病，其发病机制与凝血系统激活密切相关，但具体机制尚未完全阐明。目前，CAIS缺乏有效的筛查和治疗策略，导致其管理面临诸多挑战。因此，应重视多学科协作，加强对CAIS患者的早期识别与规范化管理，并呼吁开展更多相关临床研究。 Abstract: Cancer-associated ischemic stroke (CAIS) is a disease with complex clinical manifestations, high risk of recurrence, and poor prognosis. Its pathogenesis is closely related to the activation of the coagulation system, but the specific mechanism has not been fully elucidated. At present, CAIS lacks effective screening and treatment strategies, leading to many challenges in its management. Therefore, multidisciplinary collaboration should be emphasized, early identification and standardized management of CAIS patients should be strengthened, and more relevant clinical research should be called for.